His primary areas of study are Randomized controlled trial, Internal medicine, Surgery, Intensive care medicine and Meta-analysis. In his study, Physical therapy, Resuscitation and Evidence-based medicine is strongly linked to Clinical trial, which falls under the umbrella field of Randomized controlled trial. In his research, Lung injury is intimately related to Oncology, which falls under the overarching field of Internal medicine.
Dean Fergusson studied Surgery and Anesthesia that intersect with Relative risk, Red blood cell and Head injury. His Intensive care medicine research also works with subjects such as
Dean Fergusson mainly focuses on Internal medicine, Randomized controlled trial, Intensive care medicine, Surgery and Meta-analysis. His research investigates the connection between Internal medicine and topics such as Oncology that intersect with problems in Mesenchymal stem cell. The Randomized controlled trial study which covers Clinical trial that intersects with Protocol.
His Intensive care medicine study frequently draws parallels with other fields, such as Cohort study. His work is connected to Perioperative and Blood transfusion, as a part of Surgery. His work focuses on many connections between Blood transfusion and other disciplines, such as Emergency medicine, that overlap with his field of interest in Retrospective cohort study.
Dean Fergusson mostly deals with Internal medicine, Randomized controlled trial, Clinical trial, Meta-analysis and Oncology. His study looks at the relationship between Internal medicine and topics such as Placebo, which overlap with Strictly standardized mean difference, Low molecular weight heparin and Physical therapy. Randomized controlled trial is a subfield of Surgery that Dean Fergusson explores.
His Clinical trial study incorporates themes from Intervention, Protocol and Intensive care medicine. His Meta-analysis study combines topics from a wide range of disciplines, such as Stroke, Thrombosis, Systematic review and Animal studies. His Perioperative research focuses on Retrospective cohort study and how it connects with Blood transfusion and Emergency medicine.
His main research concerns Internal medicine, Clinical trial, Randomized controlled trial, Oncology and Adverse effect. As part of his studies on Internal medicine, Dean Fergusson often connects relevant areas like Placebo. His research in Clinical trial intersects with topics in Spontaneous intracerebral hemorrhage, Clinical research, Retrospective cohort study, Family medicine and Intensive care medicine.
His studies deal with areas such as Relative risk, Thrombosis and Disease as well as Randomized controlled trial. His studies in Oncology integrate themes in fields like Open label, Red blood cell, Transplantation and Red Blood Cell Transfusion. His Adverse effect research integrates issues from Vascular surgery, Neurology, Phases of clinical research and Systematic review methodology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion
David A Henry;Paul A Carless;Annette J Moxey;Dianne O'Connell.
Cochrane Database of Systematic Reviews (2011)
Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion.
Jeffrey L Carson;Simon J Stanworth;Nareg Roubinian;Dean A Fergusson.
Cochrane Database of Systematic Reviews (2016)
Traumatic brain injury: integrated approaches to improve prevention, clinical care, and research
Andrew I R Maas;David K Menon;P David Adelson;Nada Andelic.
Lancet Neurology (2017)
A Comparison of Aprotinin and Lysine Analogues in High-Risk Cardiac Surgery
Dean A. Fergusson;Paul C. Hébert;C. David Mazer;Stephen Fremes.
The New England Journal of Medicine (2008)
Safety of Cell Therapy with Mesenchymal Stromal Cells (SafeCell): A Systematic Review and Meta-Analysis of Clinical Trials
Manoj M. Lalu;Lauralyn McIntyre;Lauralyn McIntyre;Christina Pugliese;Dean Fergusson.
PLOS ONE (2012)
Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial.
Shawn D Aaron;Katherine L Vandemheen;Dean Fergusson;François Maltais.
Annals of Internal Medicine (2007)
Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis
Dean Fergusson;Shawn D Aaron;Gordon Guyatt;Paul Hébert.
Association of Hydroxyethyl Starch Administration With Mortality and Acute Kidney Injury in Critically Ill Patients Requiring Volume Resuscitation: A Systematic Review and Meta-analysis
Ryan Zarychanski;Ahmed M. Abou-Setta;Alexis F. Turgeon;Brett L. Houston.
Clinical consequences of red cell storage in the critically ill
Alan Tinmouth;Dean Fergusson;Ian Chin Yee;Paul C. Hébert.
Cell salvage for minimising perioperative allogeneic blood transfusion
Paul A Carless;David A Henry;Annette J Moxey;Dianne O'Connell.
Cochrane Database of Systematic Reviews (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: